SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-19-205450
Filing Date
2019-07-29
Accepted
2019-07-29 16:27:08
Documents
3
Group Members
CATALYSTA VENTURES, L.L.C.CHRISTY SHAFFERCLAY B. THORPDOUGLAS REEDHATTERAS VENTURE ADVISORS V, LLCHATTERAS VENTURE AFFILIATES III, LPHATTERAS VENTURE PARTNERS I, LPHATTERAS VENTURE PARTNERS III, LPJOHN CRUMPLERKENNETH B. LEEROBERT A. INGRAMVENTURE CAPITAL

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d785140dsc13da.htm SC 13D/A 214497
2 EX-99.7.01 d785140dex99701.htm EX-99.7.01 15361
3 EX-99.7.02 d785140dex99702.htm EX-99.7.02 6489
  Complete submission text file 0001193125-19-205450.txt   238531
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Subject) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90691 | Film No.: 19981507
SIC: 2834 Pharmaceutical Preparations

Mailing Address 280 S. MANGUM STREET, SUITE 350 DURHAM NC 27701
Business Address 280 S. MANGUM STREET, SUITE 350 DURHAM NC 27701 919-484-0730
Hatteras Venture Advisors III, LLC (Filed by) CIK: 0001674177 (see all company filings)

IRS No.: 204822068 | State of Incorp.: NC | Fiscal Year End: 1231
Type: SC 13D/A